comparemela.com

Latest Breaking News On - Ambica international corp - Page 1 : comparemela.com

FDA allows emergency use of India, US vaccines

FDA allows emergency use of India, US vaccines Red Mendoza © Provided by The Manila Times The Food and Drug Administration (FDA) has approved both the vaccines from Indian biotechnology company Bharat Biotech and a subsidiary of American pharmaceutical giant Johnson & Johnson for emergency use against Covid-19. © Provided by The Manila Times COVAXIN : India’s indigenously developed Covid-19 vaccine FDA Director-General Rolando Enrique Domingo said the two-dose Covaxin from India and the JNJ-78436735 or Janssen single-dose vaccine of Janssen Pharmaceuticals have been given emergency use authorization (EUA). Domingo added that the EUA issued to Bharat Biotech was a “conditional EUA” as the company needs to submit a certificate that would allow it to distribute the vaccine outside of their plant in India.

Concepcion to help bring Covaxin from India to Philippines

Concepcion to help bring Covaxin from India to Philippines Louella Desiderio © Bharat Biotech Concepcion to help bring Covaxin from India to Philippines MANILA, Philippines Presidential adviser for entrepreneurship Joey Concepcion said that Go Negosyo and his office will help bring Covaxin to the Philippines. The COVID-19 vaccine is manufactured by Bharat Biotech, an Indian biotechnology company. The announcement was made at a meeting with Ambica International Corp. and IP Biotech, the distributors of Covaxin. “The private sector purchases from AstraZeneca, Moderna and Novavax will be augmented by these new vaccines that will come from India. Covaxin is promising as it was the one used by Indian Prime Minister Narendra Modi and has posted 81 percent efficacy from the interim results of its phase 3 trial. It is now only awaiting FDA approval,” said Concepcion, founder of Go Negosyo.

Another COVID-19 vaccine offered to PH

Published December 21, 2020, 5:06 PM Philippine vaccine retailer, Family Vaccine and Specialty Clinics (FVSC), through IP Biotech and Ambica International Corporation, has signed an exclusive agreement with Bharat Biotech International Ltd to import and distribute COVAXIN, India’s COVID-19 vaccine candidate, upon completion of ongoing Phase 3 clinical trials and Food and Drug Administration (FDA) approval. (Photo by Robyn Beck / AFP / FILE PHOTO / MANILA BULLETIN) FVSC operates in over 40 vaccine clinics across the country and has been working closely with a network of over 25 local government units for vaccination initiatives. Ambica International Corp. meanwhile is the 5th largest pharmaceutical company in the Philippines with over 1,200 products in its portfolio.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.